NCT06159595

Brief Summary

Optimizing treatments in mental health requires an easy to obtain, continuous, and objective measure of internal mood. Unfortunately, current standard-of-care clinical scales are sparsely sampled, subject to recency bias, underutilized, and are not validated for acute mood monitoring. The recent shift to remote care also requires novel methods to measure internal mood. Recent advances in computer vision have allowed the accurate quantification of observable speech patterns and facial representations. The continuous and objective nature of these audio-facial behavioral outputs also enable the study of their neural correlates. Here, the investigators hypothesize that video-derived audio-facial behaviors have discrete neural representations in the limbic network and can provide a critical set of reliable longitudinal estimates of mood at low cost across home and clinic settings.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable major-depressive-disorder

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2023

Completed
15 days until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 7, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2025

Completed
Last Updated

November 4, 2025

Status Verified

October 1, 2025

Enrollment Period

1.9 years

First QC Date

November 16, 2023

Last Update Submit

October 31, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Quantitative Audio-Facial Change

    Quantitative percent change in each audio-facial feature before and after direct electrical stimulation at each site.

    5 minutes

  • Quantitative Mood Change

    Quantitative percent change in Immediate Mood Scaler (IMS) after direct electrical stimulation at each site compared to a baseline period before sham. The minimum score on the IMS is 7 and the maximum is 154, with lower scores reflecting more negative mood states.

    5 minutes

Secondary Outcomes (2)

  • Correlation between Audio-Facial and Mood Change

    5 minutes

  • Qualitative Mood Change

    5 minutes

Study Arms (2)

Active Direct electrical stimulation (DES)

ACTIVE COMPARATOR

Intracranial electrodes will be used for the delivery of invasive brain stimulation.

Device: Intracranial electrodes

Sham Direct electrical stimulation (DES)

SHAM COMPARATOR

Intracranial electrodes will be used for the delivery of invasive brain stimulation.

Device: Intracranial electrodes

Interventions

Surgically-implanted intracranial electrodes.

Active Direct electrical stimulation (DES)Sham Direct electrical stimulation (DES)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age range between 18 and 65
  • Major depressive disorder (MDD) in a current major depressive episode diagnosed with the Mini-International Neuropsychiatric Interview (MINI)
  • No medical or surgical contraindication to electrode implantation
  • Patient capable of understanding the scope of our project or signing informed consent independently.

You may not qualify if:

  • Diffuse epilepsy involving several lobes of the brain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Stanford, California, 94305, United States

RECRUITING

MeSH Terms

Conditions

Depressive Disorder, MajorEpilepsy

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Associate Professor

Study Record Dates

First Submitted

November 16, 2023

First Posted

December 7, 2023

Study Start

December 1, 2023

Primary Completion

October 30, 2025

Study Completion

October 30, 2025

Last Updated

November 4, 2025

Record last verified: 2025-10

Locations